
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about X4 Pharmaceuticals
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
We are a commercial-stage clinical biopharmaceutical company driven to improve the lives of people with rare diseases of the immune system and few to no treatment options. We have successfully developed mavorixafor, receiving FDA approval for XOLREMDITM (mavorixafor) in its first indication, and are currently executing our US launch. We are also advancing mavorixafor for additional rare disease patient populations, and expect to initiate a pivotal, global Phase 3 clinical trial in people with certain chronic neutropenic disorders. With a focus on CXCR4 and immune system biology, we continue to leverage our expertise both at our corporate headquarters in Boston, Massachusetts and at our research center of excellence in Vienna, Austria to further advance our patient-centric mission
C-Level 1 | VP - Level1 |
Director- | Manager17 |
Others84 |
Structure | Email Format |
---|---|
<first>.<last>@ | John.Smith@x4pharma.com |
Pain Points | Locations | Technologies |
---|---|---|
Animation | Boston, MA | communication, compliance, e, share, forecasting, data dissemination |
Application Development | Boston, MA | customer service, sas, compliance, audit, analytics, communication, integrity, operating procedures, assessment, data governance, profiling, computer networks, share, data collection, network administration, data dissemination, corrective action, data center, r, collaboration, disaster, unix, database, gmp, infrastructure, e, testing, forecasting, risk, data management, security, operations |
Application Development | Missouri, United States | communication, exchange, compliance, share, collaboration, ar |
Artificial Intelligence | Boston, MA | customer service, sas, compliance, disaster recovery, j, analytics, data infrastructure, communication, integrity, bi, share, change management, scope, machine learning, collaboration, disaster, python, hoc, database, infrastructure, sox, financial, e, sql, predictive analytics, forecasting, risk, security, operations |
Automation Testing | Boston, MA | customer service, compliance, disaster recovery, j, analytics, data infrastructure, communication, integrity, share, change management, scope, machine learning, collaboration, disaster, database, infrastructure, sox, financial, e, forecasting, risk, security, operations |
X4 Pharmaceuticals looking to hire in Application Development in Boston, MA
X4 Pharmaceuticals looking to hire in Compliance in Boston, MA
X4 Pharmaceuticals looking to hire in Digital Transformation in Boston, MA
Aws
Amazon connect
Gcp
Snowflake
Access
Analytics
Ar
Assessment
Audit
Bi
Reporting to: Vice President, General Counsel and Compliance OfficerDo you have the passion and c...
View MoreDirector, Strategic Project Management - Clinical Development and Safety Reporting to: Global Hea...
View MoreReporting to: Vice President, Clinical OperationsDo you have the passion and commitment to join a...
View MoreReporting to: VP, General Counsel and Compliance OfficerDo you have the passion and commitment to...
View MoreSenior Manager, Infrastructure Operations & Security (Temp to Perm) Reporting to: Associate Direc...
View MoreSenior Medical Science Liaison, South Central Region (TX, AZ, NM, OK, KS, MO, AR, LA)Reporting to...
View MoreReporting to: Vice President, Medical AffairsDo you have the passion and commitment to join a gro...
View MoreReporting to: Vice President, Medical AffairsDo you have the passion and commitment to join a gro...
View MoreWe are a commercial-stage clinical biopharmaceutical company driven to improve the lives of people with rare diseases of the immune system and few to no treatment options. We have successfully developed mavorixafor, receiving FDA approval for XOLREMDITM (mavorixafor) in its first indication, and are currently executing our US launch. We are also advancing mavorixafor for additional rare disease patient populations, and expect to initiate a pivotal, global Phase 3 clinical trial in people with certain chronic neutropenic disorders. With a focus on CXCR4 and immune system biology, we continue to leverage our expertise both at our corporate headquarters in Boston,...
Rare disease and primary immunodeficiencies
X4 pharmaceuticals operates in the Biotechnology research industry.
X4 pharmaceuticals's revenue is 1m - 10m
X4 pharmaceuticals has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.